Free Trial

Verrica Pharmaceuticals (VRCA) SEC Filings & 10K Form

Verrica Pharmaceuticals logo
$0.70 0.00 (-0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$0.72 +0.03 (+3.57%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Verrica Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/01/2025
7:02 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
3:45 PM
PRYGOCKI MARK A SR (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM
Eichenfield Lawrence (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM
Nguyen Diem (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM
Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:57 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/13/2025
3:36 PM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
3:19 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
5:06 AM
Verrica Pharmaceuticals (Filer)
Form DEFR14A
04/22/2025
6:15 AM
Verrica Pharmaceuticals (Filer)
Form DEF 14A
04/22/2025
6:18 AM
Verrica Pharmaceuticals (Filer)
Form DEFA14A
04/22/2025
6:20 AM
Verrica Pharmaceuticals (Filer)
Form ARS
04/02/2025
3:31 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
3:31 PM
Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2025
3:32 PM
Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
6:08 AM
Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2025
6:10 AM
Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
11:15 PM
Verrica Pharmaceuticals (Filer)
Form EFFECT
03/18/2025
5:45 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:45 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:05 PM
Verrica Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/11/2025
3:23 PM
Verrica Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
4:01 PM
ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/09/2024
5:22 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
12/09/2024
4:17 PM
Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2024
4:18 PM
Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:55 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/21/2024
3:53 PM
Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:06 PM
Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:08 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:32 AM
Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
7:59 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:02 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
8:03 PM
Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:04 PM
Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:11 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
3:17 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:15 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:16 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:37 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
A grave, grave error. (Ad)

Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one analyst who predicted the collapse of Fannie Mae and GM says the AI giant is now headed for a brutal crash… and it could hit as soon as this year.

Watch his urgent Nvidia exposé before it’s too late
09/27/2024
3:15 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM
Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:16 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:50 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
3:45 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:35 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:31 PM
Verrica Pharmaceuticals (Subject)
White Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:17 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:08 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
6:56 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:07 AM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
5:10 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:11 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:12 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:13 PM
Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRCA) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners